INSIDER
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 43h ago
HOUSE PTR3h ago
SEC 13F3h ago
ROBINHOOD CHAIN3h ago
Public company

NVCRNovoCure Ltd

CIK 0001645113

EDGAR filingsOpen in network
Disclosed transactions22
Buys / sells0 / 6
Max Insider Score46
Connections12with evidence

NVCR · disclosed activity on price

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
17
PN
Puri Michal NathChief Human Resources Officer
NVCRNovoCure Ltd
Open-market sale
SELL$8,738
660 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC FORM 4

Evidence

Verified connections

  • In industryevidence
    Pharmaceuticals, devices & health servicesSEC SIC 3841 · Surgical & Medical Instruments & Apparatus · Nov 4, 2026
  • ← Connected organizationevidence
    NOVOCURE INC. PAC (A.K.A. NOVOCURE PAC)FEC Form 1 connected organization: NOVOCURE INC. (exact legal-name match) · Nov 4, 2026
  • ← Lobbied forevidence
    TARPLIN, DOWNS & YOUNG, LLCLDA Q2 2026 second quarter · Medicare/Medicaid, Health issues · Aug 26, 2026
  • ← Lobbied forevidence
    MAYER BROWN LLP
5
PN
Puri Michal NathChief Human Resources Officer
NVCRNovoCure Ltd
Grant or award
A
$21K
1,905 sh
Jun 30, 2026
Jul 1, 2026
traded Jun 30, 2026
+1d
SEC FORM 4

Evidence

9
BB
Ben Arye BarakGeneral Counsel
NVCRNovoCure Ltd
Grant or award
A$14K
1,299 sh
Jun 30, 2026Jul 1, 2026
traded Jun 30, 2026
+1dSEC FORM 4

Evidence

9
SK
Stafford KristinDirector
NVCRNovoCure Ltd
Grant or award
A—
17.0K sh
Jun 3, 2026Jun 5, 2026
traded Jun 3, 2026
+2dSEC FORM 4

Evidence

9
OJ
Ocean Allyson JDirector
NVCRNovoCure Ltd
Grant or award
A—
17.0K sh
Jun 3, 2026Jun 5, 2026
traded Jun 3, 2026
+2dSEC FORM 4

Evidence

21
OJ
Ocean Allyson JDirector
NVCRNovoCure Ltd
Grant or award
A—
11.6K sh
Jun 3, 2026Jun 5, 2026
traded Jun 3, 2026
+2dSEC FORM 4

Evidence

21
SK
Stafford KristinDirector
NVCRNovoCure Ltd
Grant or award
A—
11.6K sh
Jun 3, 2026Jun 5, 2026
traded Jun 3, 2026
+2dSEC FORM 4

Evidence

21
PM
Paravasthu MukundChief Operating Officer
NVCRNovoCure Ltd
Grant or award
A—
58.5K sh
Mar 3, 2026Mar 5, 2026
traded Mar 3, 2026
+2dSEC FORM 4

Evidence

36
LN
Leupin NicolasFormer Chief Medical Officer
NVCRNovoCure Ltd
Open-market sale
SELL$15K
1,100 sh
Mar 4, 2026Mar 5, 2026
traded Mar 4, 2026
+1dSEC FORM 4

Evidence

17
PN
Puri Michal NathChief Human Resources Officer
NVCRNovoCure Ltd
Grant or award
A—
40.1K sh
Mar 3, 2026Mar 5, 2026
traded Mar 3, 2026
+2dSEC FORM 4

Evidence

36
PN
Puri Michal NathChief Human Resources Officer
NVCRNovoCure Ltd
Open-market sale
SELL$15K
1,100 sh
Mar 4, 2026Mar 5, 2026
traded Mar 4, 2026
+1dSEC FORM 4

Evidence

9
PN
Puri Michal NathChief Human Resources Officer
NVCRNovoCure Ltd
Grant or award
A—
58.7K sh
Mar 3, 2026Mar 5, 2026
traded Mar 3, 2026
+2dSEC FORM 4

Evidence

17
BB
Ben Arye BarakGeneral Counsel
NVCRNovoCure Ltd
Grant or award
A—
50.1K sh
Mar 3, 2026Mar 5, 2026
traded Mar 3, 2026
+2dSEC FORM 4

Evidence

9
BB
Ben Arye BarakGeneral Counsel
NVCRNovoCure Ltd
Grant or award
A—
73.3K sh
Mar 3, 2026Mar 5, 2026
traded Mar 3, 2026
+2dSEC FORM 4

Evidence

9
PM
Paravasthu MukundChief Operating Officer
NVCRNovoCure Ltd
Grant or award
A—
7,518 sh
Mar 3, 2026Mar 5, 2026
traded Mar 3, 2026
+2dSEC FORM 4

Evidence

39
BC
Brackmann ChristophChief Financial Officer
NVCRNovoCure Ltd
Open-market sale
SELL$85K
6,412 sh
Mar 4, 2026Mar 5, 2026
traded Mar 4, 2026
+1dSEC FORM 4

Evidence

17
BC
Brackmann ChristophChief Financial Officer
NVCRNovoCure Ltd
Grant or award
A—
55.1K sh
Mar 3, 2026Mar 5, 2026
traded Mar 3, 2026
+2dSEC FORM 4

Evidence

9
BC
Brackmann ChristophChief Financial Officer
NVCRNovoCure Ltd
Grant or award
A—
80.7K sh
Mar 3, 2026Mar 5, 2026
traded Mar 3, 2026
+2dSEC FORM 4

Evidence

21
PM
Paravasthu MukundChief Operating Officer
NVCRNovoCure Ltd
Grant or award
A—
45.1K sh
Mar 3, 2026Mar 5, 2026
traded Mar 3, 2026
+2dSEC FORM 4

Evidence

39
PM
Paravasthu MukundChief Operating Officer
NVCRNovoCure Ltd
Open-market sale
SELL$72K
5,377 sh
Mar 4, 2026Mar 5, 2026
traded Mar 4, 2026
+1dSEC FORM 4

Evidence

46
PM
Paravasthu MukundChief Operating Officer
NVCRNovoCure Ltd
Open-market sale
SELL$596K
43.2K sh
Mar 5, 2026Mar 5, 2026
traded Mar 5, 2026
+0dSEC FORM 4

Evidence

9
PM
Paravasthu MukundChief Operating Officer
NVCRNovoCure Ltd
Tax withholding
F$31K
2,133 sh
Jan 11, 2026Jan 12, 2026
traded Jan 11, 2026
+1dSEC FORM 4

Evidence

LDA Q1 2026 first quarter · Trade · Aug 26, 2026
  • ← Lobbied forevidence
    WILLIAMS AND JENSEN, PLLCLDA Q1 2026 first quarter · Pharmacy, Medicare/Medicaid · Aug 26, 2026
  • ← Insider ofevidence
    Ocean Allyson JDirector · Jun 5, 2026
  • ← Insider ofevidence
    Stafford KristinDirector · Jun 5, 2026
  • ← Insider ofevidence
    Puri Michal NathChief Human Resources Officer · Mar 5, 2026
  • ← Insider ofevidence
    Brackmann ChristophChief Financial Officer · Mar 5, 2026
  • ← Insider ofevidence
    Ben Arye BarakGeneral Counsel · Mar 5, 2026
  • ← Insider ofevidence
    Leupin NicolasFormer Chief Medical Officer · Mar 5, 2026
  • ← Insider ofevidence
    Paravasthu MukundChief Operating Officer · Jan 12, 2026

    • Lobbying

    $340K reported · de-duplicated
    2026 Q2 $160K in-house2026 Q1 $180K in-house
    • In-house report$160K2026 Q2 · posted Aug 26, 2026 · TAR, Medicare/Medicaid
    • TARPLIN, DOWNS & YOUNG, LLC$80K2026 Q1 · posted Aug 26, 2026 · Medicare/Medicaid, Health issues
    • WILLIAMS AND JENSEN, PLLC$60K2026 Q2 · posted Aug 26, 2026 · Pharmacy, Medicare/Medicaid
    • In-house report$180K2026 Q1 · posted Aug 26, 2026 · Medicare/Medicaid, TAR
    • MAYER BROWN LLP$20K2026 Q2 · posted Aug 26, 2026 · Trade
    • TARPLIN, DOWNS & YOUNG, LLC$80K2026 Q2 · posted Aug 26, 2026 · Medicare/Medicaid, Health issues
    • MAYER BROWN LLP$40K2026 Q1 · posted Aug 26, 2026 · Trade
    • WILLIAMS AND JENSEN, PLLC$60K2026 Q1 · posted Aug 26, 2026 · Pharmacy, Medicare/Medicaid

    Connected PAC contributions

    FEC · direct to members
    • John JoyceR$8,000NOVOCURE INC. PAC (A.K.A. NOVOCURE PAC)
    • Angie CraigD$5,000NOVOCURE INC. PAC (A.K.A. NOVOCURE PAC)
    • Lori TrahanD$5,000NOVOCURE INC. PAC (A.K.A. NOVOCURE PAC)
    • Ron WydenD$4,500NOVOCURE INC. PAC (A.K.A. NOVOCURE PAC)
    • Roger MarshallR$4,500NOVOCURE INC. PAC (A.K.A. NOVOCURE PAC)
    Mariannette Miller-MeeksR
    $4,500
    NOVOCURE INC. PAC (A.K.A. NOVOCURE PAC)
  • Nathaniel MoranR$4,000NOVOCURE INC. PAC (A.K.A. NOVOCURE PAC)
  • Chrissy HoulahanD$4,000NOVOCURE INC. PAC (A.K.A. NOVOCURE PAC)
  • Aaron BeanR$4,000NOVOCURE INC. PAC (A.K.A. NOVOCURE PAC)
  • Blake D. MooreR$4,000NOVOCURE INC. PAC (A.K.A. NOVOCURE PAC)
  • Lloyd SmuckerR$3,500NOVOCURE INC. PAC (A.K.A. NOVOCURE PAC)
  • Troy A. CarterD$3,000NOVOCURE INC. PAC (A.K.A. NOVOCURE PAC)